MabVax Therapeutics Holdings, Inc.
(Other OTC/NBB : MBVX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.09%145.210.7%$864.96m
PFEPfizer Inc. 2.06%38.200.9%$794.52m
MRKMerck & Co., Inc. 0.85%79.880.7%$633.76m
ABBVAbbVie, Inc. 0.13%84.421.9%$605.70m
BMYBristol-Myers Squibb Co. -1.05%60.121.0%$597.45m
LLYEli Lilly & Co. 0.48%142.331.1%$480.95m
AZNAstraZeneca Plc 0.08%52.001.2%$210.07m
GSKGlaxoSmithKline Plc 0.60%35.300.2%$147.41m
NVSNovartis AG 0.07%84.470.2%$138.31m
NVONovo Nordisk A/S -0.20%70.740.1%$71.09m
RGENRepligen Corp. -0.15%176.257.1%$66.58m
RPRXRoyalty Pharma Plc -0.51%39.010.2%$65.42m
SNYSanofi 0.82%49.330.2%$48.25m
AMAGAMAG Pharmaceuticals, Inc. 0.07%13.6722.1%$45.61m
OPKOPKO Health, Inc. 0.70%4.3011.2%$41.80m

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.